Wuhan Easy Diagnosis Biomedicine Co.,Ltd. 002932.SZ Stock
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Price Chart
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. 002932.SZ Financial and Trading Overview
Contents
- Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Price Chart
- Wuhan Easy Diagnosis Biomedicine Co.,Ltd. 002932.SZ Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
- Q&A For Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Stock
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. stock price | 20.35 CNY |
Previous Close | 27.63 CNY |
Open | 27.6 CNY |
Bid | 27.51 CNY x N/A |
Ask | 27.52 CNY x N/A |
Day's Range | 27.43 - 27.66 CNY |
52 Week Range | 27.09 - 52.87 CNY |
Volume | 1.84M CNY |
Avg. Volume | 3.34M CNY |
Market Cap | 6.39B CNY |
Beta (5Y Monthly) | 0.400536 |
PE Ratio (TTM) | 2.175633 |
EPS (TTM) | 2.26 CNY |
Forward Dividend & Yield | 4.71 (16.91%) |
Ex-Dividend Date | June 6, 2023 |
1y Target Est | N/A |
002932.SZ Valuation Measures
Enterprise Value | 2.68B CNY |
Trailing P/E | 2.175633 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.7598301 |
Price/Book (mrq) | 0.9716971 |
Enterprise Value/Revenue | 0.318 |
Enterprise Value/EBITDA | 0.754 |
Trading Information
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Stock Price History
Beta (5Y Monthly) | 0.400536 |
52-Week Change | -39.84% |
S&P500 52-Week Change | 20.43% |
52 Week High | 52.87 CNY |
52 Week Low | 27.09 CNY |
50-Day Moving Average | 32.54 CNY |
200-Day Moving Average | 38.74 CNY |
002932.SZ Share Statistics
Avg. Volume (3 month) | 3.34M CNY |
Avg. Daily Volume (10-Days) | 3.42M CNY |
Shares Outstanding | 232.52M |
Float | 121.73M |
Short Ratio | N/A |
% Held by Insiders | 49.47% |
% Held by Institutions | 1.81% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 3.49 |
Trailing Annual Dividend Yield | 12.63% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.24 |
Last Split Factor | 1.49:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 34.39% |
Operating Margin (ttm) | 41.62% |
Gross Margin | 57.80% |
EBITDA Margin | 42.22% |
Management Effectiveness
Return on Assets (ttm) | 30.94% |
Return on Equity (ttm) | 54.26% |
Income Statement
Revenue (ttm) | 8.42B CNY |
Revenue Per Share (ttm) | 36.86 CNY |
Quarterly Revenue Growth (yoy) | -85.00000000000000000000000000000000% |
Gross Profit (ttm) | 6.54B CNY |
EBITDA | 3.55B CNY |
Net Income Avi to Common (ttm) | 2.89B CNY |
Diluted EPS (ttm) | 12.64 |
Quarterly Earnings Growth (yoy) | -94.59% |
Balance Sheet
Total Cash (mrq) | 4.25B CNY |
Total Cash Per Share (mrq) | 18.26 CNY |
Total Debt (mrq) | 219.19M CNY |
Total Debt/Equity (mrq) | 3.19 CNY |
Current Ratio (mrq) | 3.78 |
Book Value Per Share (mrq) | 28.301 |
Cash Flow Statement
Operating Cash Flow (ttm) | 3.38B CNY |
Levered Free Cash Flow (ttm) | 2.39B CNY |
Profile of Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
Country | China |
State | N/A |
City | Wuhan |
Address | Wuhan Optics Valley International Biomed |
ZIP | N/A |
Phone | 86 27 8700 1772 |
Website | https://www.mdeasydiagnosis.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 1547 |
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and diagnostic equipment in China and internationally. Its products portfolio includes molecular diagnostic products, such as drug metabolism genetic testing and pathogen nucleic acid detection kits; and immunodiagnostic and blood gas diagnosis products. The company also provides emergency and critical illness information solutions, including information software products, supporting hardware, and certification consulting services; and third-party medical inspection services. It offers products in the areas of cardiovascular, kidney, infectious, diabetes, endocrine and metabolic, obstetrics, and gynecology diseases, as well as prenatal and postnatal care, health checkups, thyroid, hormones, blood gas, coagulation, drug metabolism, pathogen detection. The company was founded in 2008 and is based in Wuhan, China.
Q&A For Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Stock
What is a current 002932.SZ stock price?
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. 002932.SZ stock price today per share is 20.35 CNY.
How to purchase Wuhan Easy Diagnosis Biomedicine Co.,Ltd. stock?
You can buy 002932.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Wuhan Easy Diagnosis Biomedicine Co.,Ltd.?
The stock symbol or ticker of Wuhan Easy Diagnosis Biomedicine Co.,Ltd. is 002932.SZ.
Which industry does the Wuhan Easy Diagnosis Biomedicine Co.,Ltd. company belong to?
The Wuhan Easy Diagnosis Biomedicine Co.,Ltd. industry is Medical Devices.
How many shares does Wuhan Easy Diagnosis Biomedicine Co.,Ltd. have in circulation?
The max supply of Wuhan Easy Diagnosis Biomedicine Co.,Ltd. shares is 232.52M.
What is Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. PE Ratio is 9.00442500 now.
What was Wuhan Easy Diagnosis Biomedicine Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. EPS is 2.26 CNY over the trailing 12 months.
Which sector does the Wuhan Easy Diagnosis Biomedicine Co.,Ltd. company belong to?
The Wuhan Easy Diagnosis Biomedicine Co.,Ltd. sector is Healthcare.